Drugs / MET-3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04507971 | Jun 2020 → Dec 2021 | overnutrition | NuBiyota | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MET-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04507971 ↗ |
| Modality | Other / unclassified | “Human microbiome supplementation derived from bacterial strains isolated from fecal matter and grown in a laboratory environment” NCT04507971 ↗ |
| Route | Oral | “MET-3 is provided in capsule form and 5 capsules will be swallowed by each subject once daily for 4 weeks.” NCT04507971 ↗ |